Navigation Links
The Fight Against Hepatitis

The control of hepatitis outbreak has become a burning issue in Asian countries, especially with around 1.5 million clinical cases of hepatitis occurring each year.//

Looking at the main causes of this condition, we found that one of the main reason for this growing condition is due to ignorance towards prevention of the disease. In some instances, it was also found that the governments of some developing countries failed to provide basic facilities such as housing, clean drinking water and sanitation and medical healthcare to their community.

According to the World Health organization there are 400 million people in the world with hepatitis B and 75% of them live in Asia. Similarly a report has placed around 1.09 crore people to have chronic hepatitis C in India with a greater proportion of cases being reported from North Eastern India.

The predominant cause for hepatitis includes infection by the Hepatitis group of viruses. However there are other causes such as bacterial infections, excess alcohol intake, consumption of certain drugs and poisons.

Depending on the duration of hepatitis infection it is classified as acute and chronic hepatitis. What makes hepatitis a life threatening disease is that it can sometimes cause permanent liver damage or liver cancer and eventually leads to death if left untreated. Nonetheless, in many cases of chronic hepatitis treatment may become unaffordable by the underprivileged communities as treatment for liver failure or cancer means a liver transplant.

However on a positive note, even though hepatitis is growingly becoming a grave problem the prevention of the condition to a large extend is still in our hands. If one looks at the causes of this condition, one can find solutions with simple precautions like :

a) Effective blood bank screening,
b) Hepatitis B vaccination
c) Proper sanitation facilities.
d) More Community educational Programs lik
'"/>




Page: 1 2

Related medicine news :

1. Fight Heart disease and Pain with Meditation
2. Fight anemia by fortifying crops with iron!!!!!!!!
3. Fight arthritic pain with acupuncture
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Fight against E.coli
6. Red Wine Helps Fight Heart disease
7. Fish Oil Fights Arrhythmias, Sudden Death
8. SARS-Free Taiwan to Mark End Phase of Global Fight
9. Few Parents Help Kids Fight Acne
10. Common Cold Found to Fight Cancer
11. The Possibility Of Fighting HIV with Another Virus Questioned
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Fight Against Hepatitis

(Date:7/25/2008)...benefit ALS Therapy Alliance to be presented at Fe... WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/pha... a record-breaking $4.4 million in just 21 days,th... ALS research. This is,the seventh year of the ann...more than $15 million for ALS research. This year,...
(Date:7/25/2008)... New program delivers immediate cost s...hour telephone access to language interpreters] t...ltilingual solutions. , W...reg; http://www.lle-inc.com/index.html [(Languag... of interpretation, translation, and language inst...
(Date:7/25/2008)... This donation will be used to facilit...ervices for children , Ha...ww.ivci.com ), a leading integrator of enterprise... video conferencing, telepresence, audio visual in...unced today that it has donated video conferencing...
(Date:7/24/2008)...N, July 24 /PRNewswire-USNewswire/ -- Speaker Nanc...ning in support of the Tom Lantos,and Henry J. Hyd..., and,Malaria Reauthorization Act of 2008. The bil...ouse this evening by a vote of 303 to 115 and will... "Today the House took an historic vote to pass l...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2
...birth do survive into adolescence, a study conduct...lly it is believed that virtually all children inf.... But doctors working in sub-Saharan Africa have b...dmitted in HIV clinics. Researchers from the Well...
...bs with the NHS in the last quarter of 2006.The to...as per official statistics//. The job-cuts may be ...take a toll on patient care. Most of the redunda... category. Nevertheless, for those who have lost t...
...es cause a bizarre but dangerous side effect -- sl...n (FDA) has warned. Those who take the pills co...y may have no memory of having taken a tablet at a...g phone calls or fixing and eating food even while...
...which was in use even in ancient civilizations, ...//hospital settings. Scientists of the NHS who a...ich are taking over many hospitals across U.K, are...erial properties of this metal to use. Selly Oaks...
Other Medicine News:Health News:Trial Run of Copper to Combat MRSA 2
(Date:7/23/2008)...erapy to Treat the Disease -, WAYNE, N.J. and EME...,Bayer HealthCare Pharmaceuticals and Onyx Pharmac... The New England Journal of Medicine published,res...(R) (sorafenib),tablets decreased the absolute ris...able hepatocellular carcinoma (HCC), or liver canc...
(Date:7/23/2008)... Have Greater Concentrations of,Stem Cells, ARLIN.../ -- Fat removed,from the lower abdomen and inner ...lent source of stem cells, with higher stem cell c...s a Brazilian-based study in August,s,Plastic and ...urnal of the,American Society of Plastic Surgeons ...
(Date:7/22/2008)...center 293-patient European, trial -, http://ww...YT, MONTREAL, July 22 / Cr...cryotherapy products to treat cardiac,arrhythmias,... from three,European study centers using the Compa... earlier today in the Journal of the American Coll...
(Date:7/22/2008)...ma Exhibits Excellent Drug-Like ...itiation of Phase II Clinical Trials -, RESEARCH ...x BioPharma,Inc., a clinical stage company develo... diseases of the central nervous system, today ann...TM) into Phase II trials for the,treatment of depr...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Novo Nordisk Settles With Pfizer On Patent Infringement Suit 8008 1CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 1CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 2CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 3CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 4CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 5CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 6CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 7Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 1Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 2Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 3Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 4FDLI PEN co sponsor major conference on nanotechnology 1536 1FDLI PEN co sponsor major conference on nanotechnology 1536 2FDLI PEN co sponsor major conference on nanotechnology 1536 3
...est, Most Comprehensive Survey Provides New Benchm...June 21, 2007 /PRNewswire-USNewswire/ -- The,follo... -- First nationwide study of the prevalence of M... (MRSA), a virulent multi-drug resistant organism,...RSA prevalence study findings significantly exceed...
...TAIN VIEW, Calif., June 22, 2007 /PRNewswire/ -- M...ill present Phase 2,data from its Unit Dose Budeso...am at the World Asthma Meeting at the Lutfi Kirdar...key. , The oral and poster presentation entitled, ... formulation of budesonide for,nebulized delivery ...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: